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Abstract Classically, diagnosis of fungal infections is based
on microscopic examination coupled with attempts to culture
the responsible fungus from a clinical sample. For some
fungal infections (such as dermatophyte infections, infections
with dimorphic fungi, and blood stream infections with
Fusarium, Acremonium and allied genera) recovery of the
fungus in culture from a patient with clinical symptoms is
sufficient for diagnosis. However, in many cases, obtaining a
yeast or filamentous fungus in culture is not easily interpreted
in isolation. In such circumstances, decisions regarding the
clinical significance of an isolate must consider the nature of
the organism and the quantity isolated, the likelihood of it
accidentally contaminating the specimen, whether fungal ele-
ments were seen upon microscopic examination of the sam-
ple, the clinical status of the patient, and whether there are
other clinical or biological markers suggesting infection. This
review discusses these considerations for the different types of
clinical samples encountered in a microbiology laboratory.
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Introduction
As with all microbiological tests, the ability to accurately
interpret fungal culture results and identify fungi suspected
of causing infection starts with the careful selection and pro-
curement of the specimen, followed by appropriate transpor-
tation to the laboratory. Transportation at ambient temperature
is normally recommended, as some fungi are sensitive to
temperatures below 10 °C or above 30 °C. However, as fungi
and the accompanying microbial biota may continue to repli-
cate in transit, the samples should be processed as soon as
possible in order to obtain an accurate result. An important
first step is to perform direct microscopic examination to
establish the presence of yeast cells, hyphae or other fungal
elements. Such a finding will increase the likely significance
of an organism with compatible morphology subsequently
isolated in culture.
Candida albicans remains the most prevalent yeast
species causing both superficial and deep infections,
and Aspergillus fumigatus is responsible for the majority
of invasive mould infections. However, in recent years,
the number of other yeast and mould species shown to
have pathogenic potential has been increasing in line
with the increase in the number of compromised pa-
tients susceptible to fungal infection due to medical
conditions or their treatment [1–3]. Two terms have
been adopted to stem the proliferation of new disease
names each time a mould with pathogenic potential is
identified. Hyalohyphomycosis describes infection with
filamentous fungi that have hyaline (colourless) hyphae,
whilst phaeohyphomycosis describes infection with
phaeoid (darkly pigmented) moulds. More than 40 spe-
cies from 20 different genera have been isolated from
cases of hyalohyphomycosis and more than 100 species
from 60 genera are implicated in phaeohyphomycosis
[4]. In total, more than 600 species of yeast and mould
have been implicated in human infection, albeit sometimes
only as a single case history. Thus, it is becoming increasingly
apparent that no fungus isolated from a susceptible patient
should be discounted without careful evaluation. However, as
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many of the pathogenic yeasts are commensal organisms
and many of the mould pathogens are ubiquitous in the
environment and thus likely to contaminate samples or
culture plates, care should be taken during procurement
of the specimen and processing to minimise the chances
of contamination.
Direct Microscopic Examination of Samples
Direct microscopic examination of skin, hair, and nails allows
a very rapid diagnosis of dermatophyte infections, and nail
infections caused by non-dermatophyte moulds. The clinical
sample should be chopped into small pieces and a proportion
examined after digestion in 10% potassium hydroxide (KOH)
[or in the cheaper sodium hydroxide (NaOH)] [5, 6].
The ease of detection of fungal elements is greatly
facilitated by employing fluorescent brighteners such as
Calcofluor white (Sigma-Aldrich) or Blankophor
(Blankophor GmbH) in conjunction with a fluorescent
microscope [7, 8].
After liquefaction with a mucolytic agent if necessary,
respiratory samples should be concentrated by centrifugation
(3,000 g, 10 min) before direct microscopic examination.
Following centrifugation, the majority of the supernatant is
discarded, and the sediment resuspended in the remaining
small volume of supernatant. A proportion of the resulting
slurry is then mixed with 10 % KOH and fluorescent bright-
ener. The same procedure should be adopted for other body
fluids in order to concentrate any yeast cells or hyphal frag-
ments that may be present. If samples are small, as may be the
case for aqueous or vitreous humors for example, an aliquot
should be examined directly with a drop of KOH and optical
brightener. Swabs should be wiped on the surface of a glass
slide; the inoculated area should then be covered with a drop
of KOH and optical brightener before immediate direct mi-
croscopy. Tissue samples should be chopped into small frag-
ments and softened by incubation on a heat block in an
Eppendorf tube containing a few drops of KOH. For direct
microscopic examination, a portion of softened tissue should
be placed on a glass slide, covered by a drop of optical
brightener and squashed under a coverslip.
Following microscopic examination, samples should be
cultured. There are a variety of media that can be employed,
but for the majority of samples, a malt or glucose-peptone
agar, (Sabouraud’s agar) supplemented with an antibiotic,
such as chloramphenicol, to suppress attendant bacterial flora
will be suitable. Brain heart infusion agar may encourage the
yeast phase growth of the dimorphic fungi [9]. Ideally, plates
inoculated with samples from deep sites should be incubated
at 30 °C and 37 °C in air, whilst those from superficial sites
should be incubated at temperatures of ≤30 °C. Long periods
of incubation of up to six weeks may be necessary to allow the
growth of slow-growing organisms. However, most fungi
causing deep infection, with the exception of some dimorphic
pathogens, will grow within a few days, whilst dermatophytes
from superficial infections will usually be evident after one
week. In a study of 2,173 consecutive clinical cultures, in
which plates were incubated at 28 °C, 98 % of yeast
isolates and 81 % of mould isolates were detected in the
first week, and more than 96 % of moulds were detected by
day 14 [10].
Careful examination of the plates should reveal whether
any fungal isolates are associated with the area that has been
inoculated. Colonies obviously away from the inoculation
streak or tissue portion should be discounted as plate contam-
inants. If there is any doubt, an assessment of maximum
temperature of growth may be useful, as many environmental
fungi will not be able to grow at 37 °C and so would be
unlikely to cause deep infections. Isolates that are considered
significant can be identified by a variety of techniques, includ-
ing biochemical and phenotypic analysis, as well as molecular
and proteomic methods [11]. Yeasts or filamentous fungi from
blood culture or other deep sites should be identified to species
level to allow selection of the most appropriate antifungal
therapy [12, 13, 14••, 15••, 16••, 17••]. Specific susceptibility
testing of the isolates may also be useful. Table 1 lists the
organisms most likely to be implicated in infections from a
variety of clinical specimens.
Fungi Recovered from Superficial Sites—Skin, Nail
and Hair Samples
Isolation of an anthropophilic or zoophilic “true” dermato-
phyte or the relatively rare non-dermatophyte cause of skin
infection (Neoscytalidium dimidiatum) in culture from skin,
hair or nails is diagnostic of infection, regardless of whether
fungal elements were seen by direct microscopy examination.
The exception to this is with Trichophyton tonsurans, an
anthropophilic agent of tinea capitis, which is known to have
a carrier state [18]. Conversely, for the geophilic dermato-
phytes (Microsporum cookei, Trichophyton terrestre,
M. fulvum and M. gypseum), isolation in culture is less easy
to interpret, as these are potential contaminants of dermatolo-
gy samples, and clinical significance depends upon their vi-
sualisation by direct microscopy. Although a large number of
non-dermatophyte moulds have been implicated in fungal nail
infections [5, 19, 20], such infections are still relatively rare
and usually result following nail trauma. The presence of a
non-dermatophyte mould may be indicated by direct micro-
scopic examination, which demonstrates intact hyphae [as
compared to arthrospores, which are a key feature of derma-
tophyte infections (authors’ observation)] that are frequently
distorted by terminal fronding or hyphal swellings. The deci-
sion that a non-dermatophyte mould cultured from nail
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Table 1 Likely significance of isolates from a range of clinical samples
Sample Likely organisms isolated Comments on significance
Skin Dermatophyte fungi Significant if isolated
Neoscytalidium dimidiatum/hyalinum Significant if isolated
Other moulds Likely contaminants, unless as a result of disseminated infection,
e.g., Fusarium spp.
Candida spp. Significant if seen on direct microscopy
Other yeast Unlikely significance, unless as a result of disseminated infection,
e.g., Trichosporon spp. NB: Malassezia furfur is a cause of
pityriasis versicolor, but is unlikely to grow in culture
Hair Dermatophyte fungi Significant if isolated, some scalp carriage of Trichophyton
tonsurans reported
Nails Dermatophyte fungi Significant if isolated
Neoscytalidium dimidiatum/ hyalinum Significant if isolated
Scopulariopsis spp., Fusarium spp., Aspergillus spp.,
Acremonium spp.*, some rarer moulds
Significant if seen on direct microscopy and isolated in pure culture
from several pieces of nail tissue in the absence of a
dermatophyte
Candida spp. Significant if isolated from paronychia and seen on direct
microscopy
Rhodotorula spp. Often isolated, rarely significant even if seen on microscopy
Mucous membrane
swab
Yeast species May be significant if symptomatic and seen in large amounts by
direct microscopy. Also common commensals.
Dimorphic fungi Significant
Nasal swab/secretions Aspergillus spp. mucoraceous moulds Aspergillus flavus is the most common cause of fungal sinusitis,
mucoraceous moulds cause rhinocerebral mucormycosis in
appropriate patient groups
Candida spp. Likely commensals
Ear swab Aspergillus niger, other Aspergillus spp., Scedosporium
spp., Scopulariopsis spp.
Direct microscopy usually positive
Candida spp. Common commensals
Sub-cutaneous
samples
Madurella spp., Pyrenochaeta romeroi, Leptosphaeria
spp.
Cause of dark grain eumycetoma
Scedosporium spp., Acremonium spp.* Common cause of pale grain eumycetoma and subcutaneous
hyalohyphomycosis
Sporothrix schenckii Cause of sporotrichosis, tracks up lymphatic system
Cryptococcus spp. May result from disseminated infection
Alternaria spp., Exophiala spp. Cause of subcutaneous phaeohyphomycosis
Corneal tissue Fusarium spp., Aspergillus spp., Acremonium spp.*,
Candida spp.
Common causes of fungal keratitis, must be on inoculum site,
ideally with positive direct microscopy
Lasiodiplodia, Curvularia, other yeast and mould Rarer causes but significant if compliant with above
Vitreous / aqueous
fluid
Candida spp., Aspergillus spp., Fusarium spp., Usually significant, ensure on inoculum streak, confirmed by
positive direct microscopyAcremonium spp.*
Sputum Candida spp. Very rarely significant, commonly colonises airways, possible role
in deteriorating lung function in CF and ABPM patients.
Pulmonary candidosis is rare and usually a result of
haematogenous dissemination.
Cryptococcus spp. Significant
Aspergillus fumigatus, other Aspergillus
spp.,Scedosporium spp.
May be significant in the appropriate host, common colonisers in
CF patients and may contribute to deteriorating lung function




Aspergillus fumigatus, other Aspergillus
spp.,Scedosporium spp. Cryptococcus spp.
Likely to be significant in appropriate host
Significant
Dimorphic fungi Significant
Candida spp. Commonly colonise airways—very rarely significant
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specimens is clinically significant depends upon positive di-
rect microscopy, failure to culture a dermatophyte, isolation of
the non-dermatophyte mould in pure culture from a large
proportion of the clinical sample, and preferably its repeat
isolation.
Superficial candidosis is more difficult to diagnose by
microscopy and culture. Candida spp. can cause nail infec-
tions, usually associated with paronychia, or superficial skin
infections, usually intertrigo of the skin folds associated with
obesity or diabetes. The diagnosis of both nail fold infections
and Candida intertrigo depends to a large degree on clinical
presentation. Since Candida spp. are normal commensals of
the skin, recovery of these organisms in culture from skin
swabs or nail specimens is not usually significant unless direct
microscopy reveals large amounts of yeast cells/hyphae.
Malassezia spp. may also be seen on direct microscopic
examination; this can be diagnostic for the skin infection
known as pityriasis versicolor if yeast cells and short non-
branching hyphae are seen. This is especially important to
note, as the organisms will fail to grow in culture unless a lipid
source is present; for this infection, direct microscopic
examination of skin flakes is diagnostic and culture is rarely
indicated or attempted [21].
Fungi Recovered from Superficial Sites—Yeast Species
Isolated from Mucosal Sites
A variety of yeast species (principally Candida spp.) are
capable of causing mucosal candidosis (oropharyngeal or
vaginal). The clinical presentation of mucosal yeast infections
is usually quite characteristic, and is often accompanied by
typical white opaque patches of fungal growth macroscopi-
cally visible on the mucosal surface. For vaginal candidosis,
diagnosis relies upon the presence of typical symptoms, mu-
cosal appearance and the observation of the fungus in smears
or its isolation in culture in large numbers. For oropharyngeal
candidosis, isolation of the organism in culture alone is insuf-
ficient to diagnose the infection (as yeasts are normal com-
mensals of the oral cavity), which should instead be based
upon observation of large numbers of the organism in swabs
or smears from the affected area.
Table 1 (continued)
Sample Likely organisms isolated Comments on significance
Tissue biopsy Aspergillus spp., Candida spp., Cryptococcus spp.,
mucoraceous moulds, agents of hyalohyphomycosis
and phaeohyphomycosis
Positive direct microscopy enhances significance and is proof of
invasive fungal infection. Isolation in the absence of positive
microscopy should not be dismissed without careful
consideration
Dimorphic fungi Significant
Bone marrow Histoplasma spp. and other dimorphic fungi, other yeast,
Aspergillus spp.
Dimorphic fungi always significant, other yeast and Aspergilllus
usually significant
Blood Candida spp., Cryptococcus spp. Trichosporon spp.
Rhodotorula spp.
Candidaemia is the most common deep fungal infection. Other
yeast genera are seen causing fungaemia in
immunocompromised patientsMalassezia pachydermatis
Fusarium spp., Acremonium spp. *, Paecilomyces spp.,
Purpureocillium spp., Scedosporium spp.
Fusarium and Acremonium spp.* are the most common mould
genera isolated from blood during disseminated infection
Aspergillus spp. and other mould genera are usually contaminants
Dimorphic fungi Dimorphic fungi are always significant
CSF Cryptococcus spp., Candida spp., other yeast species
Aspergillus spp.
Usually significant, antigen tests can help to confirm
Dimorphic fungi Significant
Prostate fluid Dimorphic fungi, Cryptococcus spp. Significant
Peritoneal fluid Yeast isolates, Aspergillus, Paecilomyces Probably significant
Pleural fluid Cryptococcus spp., Coccidioides spp., Aspergillus spp. Cryptococcus spp. and Coccidiodes spp. may be found in pleural
fluid following pulmonary infection, other dimorphic fungi are
rare but significant if isolated. Aspergillus spp. are a rare but
significant cause of pleural effusion
Joint fluids Candida spp., dimorphic fungi, Aspergillus fumigatus Significant
Pus from abscess Candida spp., Cryptococcus spp., Sporothrix schenckii Significant
Urine (non-catheter) Candida spp., dimorphic fungi, Aspergillus spp.,
Talaromyces marneffei, Trichosporon spp.
Candida spp. are significant in symptomatic patients, other
organisms are usually found in urine as a result of deep or
disseminated infection
*The taxonomy of the genus Acremonium has recently been revised, with medically important species being re-assigned to several distinct genera
including Sarocladium and Gliomastix
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Otomycosis
If fungal infection of the ear canal is suspected, direct micros-
copy of waxy material or swabs from the area may reveal the
pathogen. As there is an air interface, mould isolates may be
able to spore within the ear canal, allowing species identifica-
tion from direct microscopic examination. The most common
isolates from this area are Aspergillus niger and Scedosporium
apiospermum [19].
Subcutaneous Infections—Mycetomas
Subcutaneous infection with certain mould species may
follow direct accidental inoculation via thorns or splinters.
Eumycetoma formation is slow but relentlessly progres-
sive, and in time may produce discharging sinuses. Pus
from these sinuses may yield hard granules that when
crushed on a microscope slide can be seen to have been
formed from compacted fungal mycelium. Granules may
be described as pale grain or dark grain, which are asso-
ciated with different fungal pathogens. Before culture,
grains should be washed to remove contaminating bacte-
ria. Pale grain mycetomas are most often associated with
Fusarium and Scedosporium species, whilst in dark grain
mycetomas, Madurella species and Pyrenochaeta romeroi
are often implicated [22].
Chorioretinitis, Endophthalmitis and Keratitis
There are a number of yeasts and moulds regularly implicated
in eye infection. Chorioretinitis and endophthalmitis usually
arise following haematogenous dissemination (endogenous
endophthalmitis), although they can also follow penetrating
ocular trauma, either accidental or surgical (exogenous en-
dophthalmitis). Yeast infections, especially due to Candida,
are far more common in this setting than those caused by
moulds, mainly Aspergillus [23]. Candida albicans was re-
sponsible for 92 % of cases in a recent review [24]. Indeed, it
is advised that all patients diagnosed with candidaemia under-
go fundoscopy to detect such infection at an early stage [25].
In contrast, keratitis usually occurs following trauma, and
moulds are more often implicated than yeasts [26]. In partic-
ular, there have been serious outbreaks of keratitis with
Fusarium species in individuals who wear contact lens fol-
lowing the use of contact lens cleaning solution that failed to
inhibit mould growth [27, 28]. The majority of cases of
postoperative and post-traumatic endophthalmitis due to
Aspergillus spp. occur in tropical areas such as India [23].
There are also more cases of non-contact-lens-associated ker-
atitis due mainly to Fusarium and Aspergillus species in Asia
and Africa; these cases often follow penetrating injuries with
vegetative material in farm workers [26, 29].
Due to the site of infection, samples of tissue, or in the case
of endophthalmitis, aqueous or vitreous fluids, are necessarily
small. Direct microscopic examination is desirable and can be
diagnostic for either yeast or mould infection, but is unlikely
to determine the infecting species. Direct species-specific or
panfungal PCR tests on such samples can provide definitive
identification [30]. However, culture is also useful, and if
successful, yields an isolate for definitive identification as well
as specific susceptibility testing, which can help to direct
appropriate therapy. Isolation in culture in the absence of other
confirmatory tests is not proof of infection. but there should be
careful consideration of the organism isolated and the likeli-
hood of its role as a pathogen. The degree of significance of an
isolate can be improved bymarking the area of the plate where
the sample has been placed. A cross or a ‘C’ streak in which a
needle or scalpel with a small piece of tissue on the end is
inoculated onto the agar in the shape of a ‘C’ is most often
employed [31]. Growth of a colony of either yeast or mould
away from this area should be viewed with suspicion as a
probable contaminant.
Respiratory Specimens—Suspected Invasive Pulmonary
Infections
Respiratory samples from cases of suspected invasive pulmo-
nary infection should first be concentrated by centrifugation
prior to culture of the sediment and incubation at 30 0C and 37
0C. It is relatively common to recover a variety of saprophytic
moulds (predominantly Aspergillus and Penicillium species)
from such samples, and in the absence of neutropenia, their
significance is often questionable [32]. The significance of a
positive culture result should be judged on the basis of the
results of direct microscopic examination, and should be taken
with some scepticism if branching fungal hyphal fragments
was not seen microscopically. This is especially important
since scant inhaled, non-germinated fungal spores are often
present in sputum samples. Such spores will frequently be
missed upon microscopic examination, and the recovery of
the organism in culture does not necessarily indicate an inva-
sive fungal infection. A caveat to this scenario is that respira-
tory specimens that have not been processed immediately may
sometimes contain germinated spores present as individual
fungal micro-colonies, with intact branching hyphae radiating
from a central point. Extra vigilance is required to distinguish
these microscopically from the fragments of branching myce-
lium (with broken hyphal ends) typically seen with either
invasive fungal infection or fungal colonisation of the air-
ways. However, the recovery of a potentially pathogenic
mould from samples from high-risk patients should always
be treated seriously, even in the absence of direct positive
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microscopy, and it is in these cases that surrogate markers
of infection can be useful adjunctive tests. The use of
high-resolut ion computed tomography (HRCT),
galactomannan on cerebrospinal fluid (CSF), bronchoal-
veolar lavage (BAL) fluid or blood, Aspergillus-specific
and pan-fungal PCR, detection of beta-glucan, and more
recently, the lateral flow device for the detection of
Aspergillus antigen, all have a role to play (see [33] for
a review, [34]). Isolation of large numbers of colonies
from any specimen could be indicative of recent exposure
to large numbers of spores, or a failure in laboratory
sterile techniques.
Respiratory Specimens—Cystic Fibrosis Patients
Despite many individual studies, there is still no single con-
sensus approach to the culture of respiratory samples from
patients with cystic fibrosis (CF) [35]. Since many of the
filamentous fungi associated with airway colonisation in CF
patients are ubiquitous in nature, and due to the excessively
viscous bronchial mucus in CF, it is again important to distin-
guish microscopically between recently inhaled spores and
growing fungal fragments in respiratory secretions from such
patients, and we would advise concentration of specimens by
centrifugation prior to microscopic examination. However,
culture of concentrated samples results in the recovery
of Aspergillus fumigatus species complex from up to
50 % of specimens, and due to the rapid growth of this
organism on most media and at most incubation temper-
atures, the recovery of other more slowly growing fila-
mentous fungi known to be important in colonisation and
exace rba t ion of lung func t ion in CF pa t i en t s
(Scedosporium spp., Exophiala dermatitidis; [35]) is like-
ly to be compromised. Indeed, serial dilution of sputum
samples from CF patients known to be persistently co-
colonised with A. fumigatus, S. apiospermum and
E. dermatitidis in our laboratory has indicated that the
latter two organisms might be present in greater quantities
(in terms of colony forming units) of 100-fold to 1,000-
fold, but are not detected when undiluted sputa are cul-
tured (unpublished data). Thus, we would advocate cul-
turing CF respiratory specimens that are both undiluted
and diluted by at least 100-fold, and incubating cultures at
30 °C and 37 °C. The most common, clinically significant
organisms recovered from CF respiratory samples include
Aspergillus spp. (predominantly A. fumigatus species com-
plex), Scedosporium spp. (predominantly S. apiospermum
species complex), E. dermatitidis, and Candida spp. (pre-
dominantly C. albicans), all of which are likely to be
clinically significant if the appropriate corresponding fun-
gal elements (mould or yeast hyphae) have been seen on
direct microscopy [35].
Respiratory Specimens—ABPA/ABPM
Allergic bronchopulmonary aspergillosis (ABPA) is a respi-
ratory disorder provoked by persistent colonisation of the
airways by A. fumigatus, and characterised by exacerbation
of asthma or CF symptoms, pulmonary infiltrates, expectora-
tion of thickened mucus plugs and immunological responses
to the fungus (pulmonary eosinophilia and elevated fungus-
specific IgE) (see [36] for review). However, it is now accept-
ed that a whole variety of fungi can cause this condition, and
the term allergic bronchopulmonary mycosis (ABPM) is more
suitable. The principal non-Aspergillus species implicated
worldwide include Candida spp., basidiomycetes (especially
Schizophyllum commune , and Trichosporon spp.),
Scedosporium spp., Fusarium spp, Cladosporium spp.,
Penicillium spp., Alternaria spp., Bipolaris spp., and
Curvularia spp. (reviewed in [36–38]). Culture of any of these
fungi from respiratory specimens from ABPM patients should
be considered significant in the presence of asthma or deteri-
orating CF lung function, eosinophilia, elevated IgE, and
transient or permanent lung x-ray abnormalities. As with
respiratory specimens from CF patients (see above), fungal
elements should normally be apparent upon direct microscop-
ic examination of centrifuged samples.
Respiratory Specimens—Dimorphic Fungal Pathogens
The dimorphic fungal pathogens Talaromyces (previously
Penicillium) marneffei, Histoplasma capsulatum var.
capsulatum, H. capsulatum var. duboisii, Blastomyces
dermatitidis, Coccidioides immitis and C. posadasii,
Paracoccidioides brasiliensis and P. lutzii can cause infec-
tions in both healthy and immunocompromised patients in
defined, endemic regions of the Americas, Africa, Asia and
Europe (depending on the particular pathogen, reviewed in
[39, 40]). For Histoplasma spp., direct microscopic examina-
tion of wet preparations of respiratory samples is very rarely
diagnostic, since the budding yeast “tissue” form of the or-
ganism is predominantly macrophage-associated (although
stained smears are more useful). For T. marneffei,
B. dermatitidis, Paracoccidiodes spp. and Coccidioides spp.,
microscopic examination of concentrated respiratory samples
can permit diagnosis if the appropriate tissue forms are ob-
served: small oval fission yeasts; large, round to oval yeast
cells with broad-based unipolar buds; large oval to round yeast
cells with multipolar, peripheral budding (“ships wheel” ap-
pearance); and thick walled spherules containing endospores,
respectively. However, the diagnostic sensitivity using KOH-
fluorescent enhancers rarely exceeds 50 % (see for example
[41–44]). The recovery of the mould form of these dimorphic
fungal pathogens requires the protracted culture of specimens
at 30 °C. In non-endemic regions, isolation of these organisms
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in culture is always clinically significant. However, even in
endemic regions, these organisms are rarely laboratory plate
contaminants, and their isolation from respiratory samples
(other than in routine surveillance studies) is likely to be
indicative of infection, especially if the patients are
symptomatic.
Blood Culture
It is usual practice to take more than one blood sample for
incubation to maximise the chance of isolation [12, 13,
45–47]. At one time, a yeast isolated from only one sample
might have been suspected of being a contaminant; however,
it has become apparent that even isolation from one bottle can
be significant and is an indication for treatment of
candidaemia [13]. For suspected catheter-related blood stream
infection, paired blood samples should be taken from the
catheter and a peripheral vein, or if this is not possible, from
different catheter lumens [45]. Isolation of a yeast species
from a line tip removed from a patient without systemic signs
of infection most often represents contamination with skin
organisms during removal and is not an indication for treat-
ment. It should be remembered that there are many Candida
species and also a number of other genera of yeast that are
regularly implicated in infection, and if isolated, should be
regarded as significant pathogens [3, 17••]. Isolation from
blood culture can be maximised by terminal sub-culture of
blood culture bottles from patients suspected of having a
fungal infection, irrespective of whether or not it has flagged
as positive [48]. Direct microscopic examination of a spun
deposit may also reveal the presence of a slow-growing or
nutritionally demanding isolate, such as aMalassezia species,
which often requires the presence of lipid to grow in culture
[49, 50]. Recent proteomic methods have focussed on identi-
fying pathogens directly in blood culture samples without the
need for sub-culture, which would overcome these problems
and abolish another potentially time-consuming step, thus
allowing earlier diagnosis and facilitating prompt institution
of appropriate antifungal therapy [11].
It is unusual to isolate filamentous fungi from blood culture
even in patients with disseminated infection. Invasive asper-
gillosis yields positive blood culture in fewer than 5 % of
patients, whereas isolation of Aspergillus fumigatus from a
single blood culture is likely to represent contamination [51].
This is because most deep mould infections are acquired by
inhalation of spores; thus, the primary site of infection is the
respiratory tract, most often the lungs. During infection, most
moulds grow as branching mycelium through the tissues and
along the blood vessels, thereby causing infection by contig-
uous spread. Occasionally, if viable fragments break off, there
may be haematogenous dissemination to remote organs, but
isolation of viable fragments from blood will be a rare
occurrence. The majority of filamentous fungi causing infec-
tion do not sporulate in vivo, so there is not production of large
numbers of infectious propagules to disseminate around the
body. Exceptions to this are with Fusarium, and less com-
monly Acremonium and related genera, which have spores
evolved for water dissemination and do have the capacity to
form spores in vivo. Aspergillus terreus may also form
chlamydoconidia in vivo, which may account for the propen-
sity of this species to cause disseminated infection. When
causing infection of deep tissues, these genera frequently
become disseminated by haematogenous spread, and about
70 % of patients with Fusarium infection will yield a positive
blood culture. A similar number will present with cutaneous
lesions due to entrapment of spores in the small capillaries of
the skin [15••, 52].
Dimorphic fungi such as Histoplasma spp., Blastomyces
spp., Paracoccidioides spp. and Talaromyces marneffei dis-
play thermal dimorphism and will be yeast forms under the
influence of body temperature in vivo. Thus, the yeast forms
will have the capacity to disseminate in the blood and may be
isolated from blood cultures, usually on prolonged incubation.
They will maintain a yeast morphology if sub-culture plates
are maintained at 37 °C, but will convert to their respective
mould forms when cultured at 30 °C. Outside endemic areas
these will always be significant, and even in endemic areas,
would very rarely be encountered as plate contaminants.
Coccidioides spp. are also dimorphic, but are unique in
forming spherules in vivo; these are large thick-walled struc-
tures that contain multiple endospores. When mature, spher-
ules, which usually originate in the lungs as infection by
inhalation of arthroconidia, will rupture, releasing multiple
endospores that disseminate. They may be isolated in blood
culture, although results are variable and not as reliable as
isolation from tissue [53]. Isolation of moulds other than
those detailed above are rarely significant, and most often
represent contamination either during taking of the spec-
imen or at some point during the processing. Contamina-
tion of blood culture with species such as Aureobasidium
pullulans , Scedosporium spp., Paecilomyces and
Alternaria is quite common [54]. However, there have
been reported fungaemias in immunocompromised pa-
tients with a variety of environmental saprobes, so there
should be careful consideration of the clinical condition of
the patient and the likely risk factors before discounting
unusual isolates.
Tissue
Direct microscopic examination of biopsy or autopsy samples
stained with optical brighteners or histological stains can
enhance the significance of a subsequent isolate with compat-
ible morphology. Direct microscopy can be diagnostic for
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yeast infection, including the yeast forms of dimorphic path-
ogens, coccidioidomycosis in which spherules may be
visualised, mucormycosis, hyalohyphomycosis or
phaeohyphomycosis. Visualization of fungal elements is suf-
ficient for proof of invasive fungal infection [55]; however,
culture is important, as it can yield an isolate for species
identification and possible susceptibility testing, both of
which can help to direct appropriate antifungal therapy. Tis-
sues for fungal culture should not be homogenised, as this will
disrupt hyphae and may lead to the formation of nonviable
mycelial fragments. This is especially likely with
mucoraceous moulds, which have few septa to wall off hyphal
damage, which means that even quite large fragments may
have lost their cytoplasmic contents and become nonviable.
This is one of the reasons why culture and even PCR methods
may be unsuccessful even when fungal hyphae have been
seen on direct microscopic examination. Therefore, if fungal
infection is suspected, tissue samples should be chopped into
1 mm pieces, placed on the surface of an appropriate agar, and
incubated at 30 °C and 37 °C. Cultures should be examined
for the presence of fungal growth after 24 hours and then at
regular intervals for up to 6 weeks, depending on the pathogen
that is suspected. Hyphae can often be seen emerging
from the tissue sample by direct microscopy of the plate
or slope even before growth of the colony becomes
visible to the naked eye.
Subcutaneous infection may follow accidental inoculation
of moulds with either hyaline (hyalohyphomycosis) or darkly
pigmented (phaeohyphomycosis) hyphae. These infections,
which are most common in individuals with immunological
defects, such as renal transplant recipients on tacrolimus, do
not present as mycetomas, but on microscopic examination
sparse fungal elements may be seen in the tissues. Organisms
implicated in these infections include: Scedosporium,
Exophiala, Cladophialophora, and Alternaria spp. [56–59].
Other deep mould infections are most common in patients
who are immunocompromised. Aspergillus fumigatus is by far
the most common mould causing invasive infection and cere-
bral aspergillosis is a well-described complication; however, it
is also a common contaminant, so careful evaluation is re-
quired. Infection with the organisms Cladophialophora
bantiana, and to a much lesser extent Cladophialophora arxii
and Cladophialophora devresii, which are classified in the
European scheme as Hazard Group 3, most often present as
cerebral infection, usually in young Asian males, whereas
Rhinocladiella mackenzei has a similar presentation in pa-
tients from the Middle East [60]. Darkly pigmented hyphae
may be seen in pus from these lesions or penetrating
the brain tissue in biopsy samples. Aspergillus flavus is
the most common cause of fungal sinus infection in
immunocompetent individuals [61]; in immunocompro-
mised or diabetic individuals, mucoraceous moulds are
more common [14••].
Conclusions
Whilst isolation in culture alone may be diagnostic for some
fungal infections, direct microscopic observation with optical
brighteners or histological stains greatly enhances the signif-
icance of subsequent isolation of a fungus with compatible
morphology. Radiological methods, such as CT scans, can
identify abnormal areas and help to direct appropriate sam-
pling. In the absence of confirmatory direct microscopy, con-
sideration should be made of the amount and species of any
fungus isolated and its ability to grow at 37 °C, as well as the
nature of underlying predisposing factors. Examination of
other biomarkers of infection, such as antibody and antigen
detection and PCR tests, can help to confirm infection. In a
high-risk patient, no fungal isolate obtained in culture should
be discounted without careful evaluation.
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